Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Advances in siRNA therapeutic technology

Nov. 5, 2015

Ultragenyx and Arcturus collaborate to develop mRNA therapeutics for rare diseases

Nov. 2, 2015

Japan's MHLW grants Sakigake designation to six drugs

Oct. 28, 2015

Vertex and CRISPR Therapeutics establish research collaboration

Oct. 28, 2015

Arrowhead describes targeted RNAi therapeutics for HBV, renal cell carcinoma, cardiovascular disease

Oct. 27, 2015

Novo Nordisk licenses use of Emisphere's Eligen technology for oral drug development

Oct. 19, 2015

Rock Creek completes phase I trial of oral formulations of anatabine citrate

Oct. 19, 2015

Johnson & Johnson Innovation announces new collaborations

Oct. 16, 2015

Boehringer Ingelheim starts phase I trial of BI-655130

Oct. 14, 2015

Caribou Biosciences and DuPont partner to develop CRISPR-Cas technology

Oct. 13, 2015

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...